← back to picks
Reporting EUR Credit Aaa/AAA Valuation 2026-05-25 Damodaran FCFF · 1000-iter MC Verdict 🟡 Mixed · Council pressure-tested FCFF · Dark v3

LNG-EPC oligopolist priced for guidance-cut malaise · +39% MoS

MC band entirely above market

€20bn backlog (2.8× revenue) intersects an April guide cut that the market over-discounted. Intrinsic €58.40/sh post-governance vs market €35.76/sh; MC P50 €57.33/sh, and even the p5 outcome (€50.47/sh) clears market by +29%. Council-revised 10% governance haircut already applied. P(intrinsic < market) = 0%.

p50 €57.3 DCF €58.4 market €35.76 p5 €50.5 p95 €64.3 Engineering/Construction59% Africa/ME revenueβ 0.60 (5Y regression, multi-source)MC σ €4.21/shGov 10%Insider tape: net sellerInvestment grade · €1bn net cash
Intrinsic / share
€58.40
post 10% gov · pre €64.89
Market / share
€35.76
Euronext Paris close
Margin of safety
+38.8%
vs intrinsic
Enterprise value
€8.77B
70.8% terminal
Cost of equity / debt
6.26% / 2.31%
β 0.60 · CRP 1.70%
Terminal ROIC / g
14.06% / 2.50%
spread ~834bp vs WACC

What it sells, where it sells

Operating segments — FY25 revenue €7.19B

Base €7.19B
Project DeliveryLNG / petchem / H2 EPC — EBIT 7.0%~75%
Technology, Products & ServicesProcess tech, licensing, AM&C catalysts — EBIT ~10%~25%

Source: FY25 results press release + Capital Markets Day 2024 segment frameworks.

Country mix (revenue-weighted CRP input)

🇶🇦Qatar40.0%
🇺🇸United States15.0%
🇫🇷France12.0%
🇦🇪UAE8.0%
🇲🇿Mozambique6.0%
🇸🇦Saudi Arabia5.0%
🌏Other (MY · ID · SR · NL)14.0%

Africa & Middle East represents 59% of revenue (Qatar alone 40%). Single-counterparty bargaining-power exposure to QatarEnergy/Aramco — drives both elevated country risk premium AND a margin-ceiling overhang the FCFF DCF only partially captures.

Background — five things to know before the case

Context the share price doesn't carry on its face. Skim this once and the bull / bear bullets below stop reading as inside baseball.

Technip Energies spun out of TechnipFMC in Feb 2021. Two segments: Project Delivery (~75% of FY25 revenue) executes large-scale EPC for LNG, petrochemicals, hydrogen, and CO2 management; Technology, Products & Services (~25%) licenses process technology, sells proprietary equipment, and — since the 2025 Advanced Materials & Catalysts (AM&C) acquisition — provides catalyst materials. It is one of only three end-to-end LNG EPC franchises globally (with KBR and JGC), a structural moat the model encodes via above-industry sales-to-capital (2.50 vs 1.86 median) and a 290bps premium on year-10 EBIT margin (8.0% vs 5.1% E&C median).

The April 30, 2026 guidance cut — Project Delivery revenue €5.7-6.3bn (was €6.3-6.7bn), EBITDA margin 6.5-7.5% (was ~8%) — is the immediate price driver. Management attributed it to Iran/Hormuz disruption deferring €500-600M of 2026 revenue with project-cost-recovery protections. Q1 2026 missed across the line (rev -4%, EBITDA -8%, net profit -20%), but Q1 order intake of €6bn+ already exceeded all of FY25 and pushed the adjusted backlog above €20bn — 2.8× revenue. The bear-vs-bull tension is whether the guide cut is event noise on a structurally strengthening backlog or the first crack in a cycle peak.

Where we diverge from the sector

Each row asks: if we'd used the sector median for this one assumption instead of our override, how much would the share price change? Negative = our override is more conservative (worth less); positive = more aggressive (worth more). Skim down the rightmost column to see which bets are doing the work.

Assumption
Our input
Sector median
Value impact
01Revenue growth10-year CAGR
5.5% Y1-5Mid of 5-7% band; CMD2028 7.4% haircut for cycle risk
7.4%Mgmt CMD2028 path
−€3.20
02Operating marginYear-10 steady state
8.0%TPS mix 25→30% + AM&C bolt-ons; blended 8.5% rounded for slippage
5.1%E&C median
+€8.40
03Sales-to-capitalReinvestment efficiency
2.50Asset-light (1.25% capex/rev) + structurally negative WC
1.86E&C median
+€2.10
04Terminal growthYear 10+ steady state
2.5%Below EUR risk-free; EPC cyclicality + post-2030 LNG uncertainty
2.7%EUR risk-free ceiling
−€0.30
05Cost of capitalWACC, 10-year average
5.72%β 0.60 (5Y market regression, multi-source; Damodaran global re-levered would give 0.85 — triangulation triggered, regression won)
9.16%US-subset β 1.14 (48 firms), re-levered at D/V 21%
+€9.10
Net effect of overrides
Overrides net +€16.10/share vs all-defaults · the +290bp margin premium (TPS mix) and the regression-anchored β (0.60 vs US-subset 1.27) do most of the work, partly offset by a CMD-haircut growth and a 10% governance haircut. The thesis is that the LNG-EPC oligopoly + the AM&C lever are real — strip them out and you get back to roughly market price.
+€16.10
Our override Sector median Override adds value Override subtracts value

The story & the five claims

The 10-year story this DCF is built on, plus the five anchor claims that translate the story into model inputs.

The 10-year story

The story is mix-driven, not pricing-power-driven. Project Delivery margins are stuck in a 6-8% band regardless of backlog — they're fixed-price lump-sum contracts against Saipem, McDermott, and JGC, with the client (QatarEnergy/Aramco) capturing most of the LNG-scarcity rent. TPS is the lever: 9.2-9.6% EBIT for four consecutive years, AM&C lifting pro-forma TPS EBITDA +120bps to >14%, and management's stated capital allocation priority is more TPS-focused tuck-ins. If TPS grows from 25% to 30% of revenue by year 10 (consistent with the CMD2024 M&A cadence of €100-200m/yr at 10× EBITDA), blended EBIT margin lands at 8.5%, which the narrative rounds to 8.0% for execution slippage. Anything above 8.5% requires the LNG oligopoly thesis to fully crystallize — which is the Expansionist scenario, not the base case.

Two debates worth pressure-testing

Q. Why isn't the terminal margin a 10 handle if TE is in a 3-player LNG EPC oligopoly?

Because TE bids fixed-price LSTK contracts; KBR's higher margins come from a diversified book including US government work, not from LNG scarcity rent capture.

Q. Is the 5.5% Y1-5 growth conservative vs mgmt's 7.4% CMD?

Yes — explicitly. The CMD path is empirically validated through FY25; the 5.5% reflects a haircut for the Hormuz event becoming a regime, not just an episode. MC high case 7.2% captures the mgmt path.

Q. CEO sold 57% of his stake at €26-31. Doesn't that contradict the BUY?

It's the strongest disconfirming signal in the file and why the governance discount sits at 10% rather than 5%. The 10% haircut converts the insider tape into a quantitative penalty the valuation respects.

Q. ROIC compressed from 15% to 9%. How does the DCF expand margins from here?

First Principles' point: the ROIC denominator is largely cash, so reported ROIC compression is partly a measurement artifact. The 8.0% margin claim ties to mix shift, not core PD margin expansion — these are separable.

Q. What's not in the model that should worry you?

FX translation (USD revenue / EUR reporting; a 10% move ≈ 150bps margin), lump-sum turnkey tail risk (one bad megaproject), and working capital reversal post-2027 if backlog burns without replacement.

CLAIM 01 Revenue growth Y1-5: 5.5%. €20bn backlog + Q1 €6bn intake Locks 2026-28 visibility; CMD2028 path of 7.4% haircut to 5.5% for post-2028 cycle risk.
CLAIM 02 Year-10 EBIT margin: 8.0%. +290bp vs E&C median 5.1% TPS mix 25→30% + AM&C bolt-ons. Council-flagged as the weakest link in the thesis.
CLAIM 03 Sales-to-capital Y6-10: 2.50. vs E&C median 1.86 Asset-light + negative WC. Structurally meaningless given near-zero invested-capital base.
CLAIM 04 Terminal growth: 2.5%. Just below EUR rf 2.7% EPC cyclicality + post-2030 LNG demand uncertainty caps terminal below risk-free.
CLAIM 05 Convergence year: Y7. Pushed from Y5 (council/Executor revision) April guide cut + ROIC 15%→9% compression argues against a 5-year operational recovery.
Where we diverge from sell-side

The market is pricing TE at €35.76 — a roughly 15× P/E on 2026E earnings — which assumes either (a) the Hormuz disruption is a regime change, not an event, or (b) the LNG capex super-cycle peaks before FY28 and TPS adjacencies fail to backfill. The DCF (and 4 of 5 sell-side analysts) say the opposite: that 5.5% organic growth on a 2.8× revenue backlog, with 8% terminal margin and 10% governance haircut, is worth €58.40/sh — a ~39% margin of safety. Even the MC p5 outcome (€50.47) clears the market price by +29%, which is unusually robust.

  • WACC re-corrected via β triangulation. Earlier pass used Damodaran's US Eng/Construction subset (β_u 1.14, β_lev 1.27), giving WACC 9.16%. A correction to global (β_u 0.76, β_lev 0.85) gave WACC 7.00%, but the multi-source 5Y regression β for TE is 0.60 (Yahoo, StockAnalysis, SimplyWallSt all between 0.57 and 0.67). The 42% gap between regression and Damodaran-global triggers triangulation → trust regression. LNG-EPC backlog (€20B) makes TE's covariance with the broad market lower than the global Eng/Construction aggregate suggests. Final: β 0.60, Ke 6.26%, WACC 5.72%, MoS +38.8%.
Two-sided case — bear anchors

The bear case is not in the model: it's the four unmodeled risks the council surfaced. FX translation on USD-pegged ME revenue could swing reported margin ±150bps. One bad LSTK megaproject (Saipem 2014, McDermott 2019 precedents) could wipe multiple years of margin. Post-2027 backlog burndown without equivalent replacement triggers a working-capital reversal that flips the net-cash story. And the insider tape — CEO sold 57% of stake at €26-31, Bpifrance trimming — is hard to override with a model, however well-anchored. The DCF answer is "BUY at p5"; the council answer is "BUY with humility, sized small enough to absorb an LSTK write-down."

Risks to thesis (tail, not bear case)

Hormuz / Qatar concentrationHIGH

40% of revenue. April 30 guide cut already showed the channel; a second escalation could defer revenue beyond 2027.

LSTK megaproject cost overrunHIGH

Fixed-price contracts. One bad train write-down (Saipem/McDermott precedents) wipes years of margin.

Working capital reversal post-2027MED

€1bn net cash is largely client-advance funded. Backlog burndown without replacement = negative FCF.

FX translationMED

USD revenue / EUR reporting. 10% EUR/USD move ≈ ±150bps margin — swamps the 7.2→8.0 bridge.

Insider tapeMED

CEO sold 57% of stake at €26-31; Bpifrance ABO of 3.57M shares May 7. Captured in 10% governance haircut.

ROIC compressionWATCH

15%→9% over 3y. Partly cash-denominator artifact; partly real (incremental capital lower-returning than legacy).

10-year forecast

Revenue €7.58B → €11.59B over 10y (~5.5% CAGR Y1-5 tapering to 2.5% terminal); EBIT margin lifts from 7.2% base to 8.0% by year 7 as TPS mix shifts 25→30%.

Y1 Y2 Y3 Y4 Y5 Y6 Y7 Y8 Y9 Y10 0 11.6B rev (EUR) 0% 10% op margin revenue FCFF op margin

Monte Carlo distribution

Asymmetric: 0% of MC iterations produce intrinsic below the €35.76 market price. Even the p5 outcome (€50.47/sh, +29%) clears market — meaning the undervaluation is robust to joint perturbation of the four sampled axes (growth, margin, terminal, governance). The unmodeled risks (FX, lump-sum turnkey tail, WC reversal) still apply.

1000 iterations randomising the central uncertainties. P(intrinsic < market €35.76) = 0.0%.

p5 p25 p50 p75 p95 market 35.76 34.3 57.3 72.4 freq equity / share (EUR)

Mean €57.23 ± €4.21/sh, p5 €50.47 → p95 €64.28.

Cost of capital build
Risk-free rate 2.70%
Mature-market ERP 4.30%
Levered β 0.60
Weighted CRP 1.70%
Cost of equity 6.26%
Pre-tax cost of debt (synth Aaa/AAA) 2.31%
D / V ~21%
WACC 5.72%
Full year-by-year DCF
Year Revenue Op mgn EBIT EBIT(1−t) Reinvest FCFF PV
1 €7.58B 7.28% €552M €388M €158M €230M €211M
2 €8.00B 7.40% €592M €416M €167M €250M €209M
3 €8.44B 7.52% €635M €446M €176M €270M €208M
4 €8.90B 7.64% €680M €478M €186M €293M €206M
5 €9.39B 7.76% €729M €513M €196M €317M €204M
6 €9.91B 7.88% €781M €556M €207M €349M €206M
7 €10.45B 8.00% €836M €602M €218M €384M €208M
8 €10.93B 8.00% €874M €636M €188M €448M €223M
9 €11.31B 8.00% €905M €666M €153M €513M €236M
10 €11.59B 8.00% €927M €691M €113M €578M €247M
Methodology & flags

Damodaran FCFF DCF, 10y explicit + perpetuity. Synthetic credit Aaa/AAA; cost of debt 2.31%. CRP 1.70% from revenue-weighted country mix (Qatar 40 / US 15 / France 12 / UAE 8 / Mozambique 6 / Saudi 5 / others). Operating leases not capitalized (IFRS 16 already on book debt). Governance discount 10% applied per Step-2 context check + council. Monte Carlo: 1000 iterations over 4 axes (rev growth, op margin, terminal growth, governance discount). Engine v1.0.0 · result: valuations/te/output/2026-05-25-result.json

  • R&D cap: OFF · Lease cap: OFF · Failure: OFF · ESO: OFF
  • Governance discount: 10% (€64.89 → €58.40)
  • Sensitivity tornado: not run (MC supersedes)